Skip to content
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
Menu
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
accuray-logo-20
  • Who We Are
    • –
  • Resources
    • –
  • Products
    • –
  • Services
    • –
Menu
  • Who We Are
    • –
  • Resources
    • –
  • Products
    • –
  • Services
    • –
Search
Close
accuray-logo-20.svg

Date: 2019

Clinical Results After Single-fraction Radiosurgery for 1,002 Vestibular Schwannomas

Windisch PY, Tonn JC, Fürweger C, Wowra B, Kufeld M, Schichor C, Muacevic A | Cureus | 2019

Clinical Efficacy of CyberKnife Radiosurgery for Adult Brainstem Glioma: 10 Years Experience at Tianjin CyberKnife Center and Review of the Literature

Zhang J, Liu Q, Yuan Z, Zhao L, Wang X, Wang P | Front Oncol | 2019

Multisession radiosurgery for perioptic meningiomas: medium-to-long term results from a CyberKnife cooperative study

Marchetti M, Conti A, Beltramo G, Pinzi V, Pontoriero A, Tramacere I, Senger C, Pergolizzi S, Fariselli L | J Neurooncol | 2019

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis

Conti A, Senger C, Acker G, Kluge A, Pontoriero A, Cacciola A, Pergolizzi S, Germanò A, Badakhshi H, Kufeld M, Meinert F, Nguyen P, Loebel F, Vajkoczy P, Budach V, Kaul D | Radiat Oncol | 2019

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases

Martinage G, Geffrelot J, Stefan D, Bogart E, Rault E, Reyns N, Emery E, Makhloufi-Martinage S, Mouttet-Audouard R, Basson L, Mirabel X, Lartigau E, Pasquier D | Front Oncol | 2019

A Second Course of Stereotactic Image-Guided Robotic Radiosurgery for Patients with Cerebral Metastasis

Jiang X, Wang H, Song Y, Wang X, Li F, Dong Y, Wang J, Chen H, Yuan Z | World Neurosurg | 2019

Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis

Scotti V, Bruni A, Francolini G, Perna M, Vasilyeva P, Loi M, Simontacchi G, Viggiano D, Lanfranchi B, Gonfiotti A, Topulli J, Olmetto E, Maragna V, Ferrari K, Bonti V, Comin C, Balduzzi S, D’Amico R, Lohr F, Voltolini L, Livi L | Clin Lung Cancer | 2019

5-year Biochemical Outcomes of Stereotactic Body Radiotherapy with Intraprostatic Dose Escalation for Unfavorable Prostate Cancer

Blacksburg SR, Aghdam N, Royce TJ, Burri RJ, Obayomi-Davies O, Mezeckis M, Meier R, Fuller DB, Chen RC, Lanciano RM, Haas JA, Collins SP | Int J Radiat Oncol Biol Phys | 2019

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Brand DH, Tree AC, Ostler P, van der Voet H, Loblaw A, Chu W, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Henderson D, Brown S, Cruickshank C, Burnett S, Duffton A, Griffin C, Hinder V, Morrison K, Naismith O, Hall E, van […]

Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

Senger C, Conti A, Kluge A, Pasemann D, Kufeld M, Acker G, Lukas M, Grün A, Kalinauskaite G, Budach V, Waiser J, Stromberger C | BMC Urol | 2019

Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases

Stintzing S, Einem JV, Fueweger C, Haidenberger A, Fedorov M, Muavcevic A | Cancer Res Treat | 2019

Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases

Anstadt EJ, Shumway R, Colasanto J, Grew D | J Gastrointest Oncol | 2019

Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer

Sumodhee S, Bondiau PY, Poudenx M, Cohen C, Naghavi AO, Padovani B, Maneval D, Gal J, Leysalle A, Ghalloussi H, Otto J, Doyen J | BMC Cancer | 2019

Efficacy and Feasibility of Salvage Re-Irradiation with CyberKnife for In-Field Neck Lymph Node Recurrence: A Retrospective Study

Kobayashi D, Sato H, Saitoh JI, Oike T, Nakajima A, Noda SE, Kato S, Iwanaga M, Shimizu T, Nakano T | J Clin Med. | 2019

newer →
Facebook-f Linkedin Twitter Youtube
  • CyberKnife®
  • Radixact®
  • TomoTherapy®
  • Accuray Precision® Treatment Planning
  • iDMS® Data Management
Menu
  • CyberKnife®
  • Radixact®
  • TomoTherapy®
  • Accuray Precision® Treatment Planning
  • iDMS® Data Management
  • Careers
  • Services
  • Patients
  • Investors
  • Contact Us
Menu
  • Careers
  • Services
  • Patients
  • Investors
  • Contact Us
  • Conflict Minerals Policy Statement
  • Privacy Policy
  • Terms of Use
  • EthicsPoint Hotline
  • Cookie Use Notice
  • India eWaste Management Program
  • Trademarks
Menu
  • Conflict Minerals Policy Statement
  • Privacy Policy
  • Terms of Use
  • EthicsPoint Hotline
  • Cookie Use Notice
  • India eWaste Management Program
  • Trademarks

Safety Statement for Radiation Treatment:
Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death. Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient’s general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.

© 2023 Accuray Incorporated, All Rights Reserved. The stylized Accuray logo, CyberKnife, VSI, M6, TomoTherapy, H Series, Tomo, TomoH, TomoHD, TomoHDA, TomoEDGE, TomoHelical, TomoDirect, Hi·Art, PlanTouch, PreciseART, PreciseRTX, Radixact, Accuray Precision, iDMS, Iris, Xchange, RoboCouch, InCise, MultiPlan, Xsight, Synchrony, InTempo, TxView, PlanTouch, QuickPlan, TomoHelical, TomoDirect, TomoEDGE, CTrue, ClearRT, VoLO, Planned Adaptive, TQA, TomoLink, TomoPortal, OIS Connect and AERO are trademarks or registered trademarks of Accuray Incorporated, in the United States and other countries and may not be used or distributed without written authorization from Accuray Incorporated. Use of Accuray Incorporated’s trademarks requires written authorization from Accuray Incorporated.

  • Home
  • AI Real-time Tracking
  • Hypofractionation Trend
  • 20+ Years of Evidence
  • Adaptation in Action
  • CyberKnife® S7™
  • Radixact®
Menu
  • Home
  • AI Real-time Tracking
  • Hypofractionation Trend
  • 20+ Years of Evidence
  • Adaptation in Action
  • CyberKnife® S7™
  • Radixact®
Who we are
  • Company
  • Leadership
  • Careers
  • Locations
  • News
  • Media
  • Events
  • Partners
  • Investors
Resources

  • 20+ Years of Evidence
  • Blog
  • Innovation
  • Case Studies
  • Patients
  • Product Resources
  • Veterinary Oncology
  • Cybersecurity

Treatment Centers

Find a Facility Near You

Products
  • Overview
  • Entrega do Tratmento
  • Resources
  • Overview
  • Entrega do Tratmento
  • Resources
  • Overview
  • Entrega do Tratamento
  • Resources
  • Accuray Precision® Treatment Planning
  • PreciseART®
  • PreciseRTX®
  • iDMS® Data Management
  • Synchrony®
  • RayStation®
  • RayCare®
Services
  • Service Overview
  • Site Planning and Installation
  • Training
  • CyberKnife®
  • Radixact®
  • Technology Upgrades
  • Service Support
  • Customer Resources
  • AERO™ Community
  • Service Requests
  • Contact Us
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
Menu
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
  • English

Unmatched service to protect uptime and maximize ROI

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

  • Service Overview
  • Site Planning And Installation
  • Training
  • CyberKnife®
  • Radixact®
  • Alliance Advances
  • Service Support
  • Customer Resources
  • Contact
  • Overview
  • Treatment Delivery
  • Resources
  • Overview
  • Treatment Delivery
  • Resources
  • Overview
  • Treatment Delivery
  • Resources
  • Accuray Precision® Treatment Planning
  • PreciseART®
  • PreciseRTX®
  • iDMS® Data Management
  • Synchrony®
  • RayStation®
  • RayCare®

Redefining the future of cancer care

Learn how Accuray radiation technologies enable clinicians to get patients back to living their lives, faster. Explore coming innovations that unlock entirely new possibilities.

Treatment Centers

Find a Facility Near You
  • 20+ Years of Evidence
  • Blog
  • Innovation
  • Case Studies
  • Patients
  • Product Resources
  • Veterinary Oncology
  • Cybersecurity

Accuray treatment options

The following pages explore some of the many ways clinicians around the globe use Accuray technologies to deliver unique and effective treatments for a wide range of clinical indications.

Treatment Centers

Find a Facility Near You

Breast

  • IMRT with TomoHelical™
  • 3DCRT with TomoDirect™

Intracranial

  • SRS with CyberKnife ®

Prostate

  • SBRT with CyberKnife®

Lung

  • SBRT with CyberKnife®

Head and Neck

  • IMRT with TomoHelical™

Veterinary

  • Veterinary Oncology with
    CyberKnife® & TomoTherapy®

About Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.

  • Company
  • Leadership
  • Careers
  • Locations
  • News
  • Media
  • Corporate Citizenship
  • Events
  • Partners
  • Investors